Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling

Core Insights - Quanterix Corporation announced the publication of a significant study in JAMA Network Open, highlighting its role in advancing healthcare through biomarker research [1] Company Overview - Quanterix Corporation is focused on transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics [1] Study Details - The study was conducted by researchers at Amsterdam UMC and followed nearly 300 individuals for up to 15 years [1] - The findings of the study are expected to have a substantial impact on the understanding of biomarkers in healthcare [1]